259 related articles for article (PubMed ID: 16210847)
21. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
[TBL] [Abstract][Full Text] [Related]
22. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
[TBL] [Abstract][Full Text] [Related]
23. Screening newborns for candidate biomarkers of type 1 diabetes.
McGuire JN; Eising S; Wägner AM; Pociot F
Arch Physiol Biochem; 2010; 116(4-5):227-32. PubMed ID: 20868220
[TBL] [Abstract][Full Text] [Related]
24. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
25. Proteomic profiling of growth hormone-responsive proteins in human peripheral blood leukocytes.
Chung L; Nelson AE; Ho KK; Baxter RC
J Clin Endocrinol Metab; 2009 Aug; 94(8):3038-43. PubMed ID: 19491220
[TBL] [Abstract][Full Text] [Related]
26. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.
Ciavarella D; Mastrovincenzo M; D'Onofrio V; Chimenti C; Parziale V; Barbato E; Lo Muzio L
Prog Orthod; 2011 Nov; 12(2):126-31. PubMed ID: 22074837
[TBL] [Abstract][Full Text] [Related]
27. [Screening of serum protein biomarkers by surface-enhanced laser desorption and ionization with time-of-flight detection mass spectrometry in patients with mycosis fungoides].
Liu J; Zheng YH; Zhang JZ; Wang BX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):13-6. PubMed ID: 19317049
[TBL] [Abstract][Full Text] [Related]
28. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
29. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy.
Yang YH; Zhang S; Cui JF; Lu B; Dong XH; Song XY; Liu YK; Zhu XX; Hu RM
Diabet Med; 2007 Dec; 24(12):1386-92. PubMed ID: 18042080
[TBL] [Abstract][Full Text] [Related]
31. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
32. Influence of sample storage duration on serum protein profiles assessed by surface-enhanced laser desorption/ionisation time-of-flight mass spectrometry (SELDI-TOF MS).
Gast MC; van Gils CH; Wessels LF; Harris N; Bonfrer JM; Rutgers EJ; Schellens JH; Beijnen JH
Clin Chem Lab Med; 2009; 47(6):694-705. PubMed ID: 19416081
[TBL] [Abstract][Full Text] [Related]
33. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
34. Quality control and quality assessment of data from surface-enhanced laser desorption/ionization (SELDI) time-of flight (TOF) mass spectrometry (MS).
Hong H; Dragan Y; Epstein J; Teitel C; Chen B; Xie Q; Fang H; Shi L; Perkins R; Tong W
BMC Bioinformatics; 2005 Jul; 6 Suppl 2(Suppl 2):S5. PubMed ID: 16026602
[TBL] [Abstract][Full Text] [Related]
35. [Detection of tissue protein biomarkers by surface enhanced laser desorption/ionization-time of flight-mass spectrometry in patients with mycosis fungoides].
Liu J; Zheng YH; Zhou YF; Zhang JZ; Wang BX
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(2):100-4. PubMed ID: 19489271
[TBL] [Abstract][Full Text] [Related]
36. Limitations in quantitation of the biomarker CCL18 in Gaucher disease blood samples by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
van Breemen MJ; Bleijlevens B; de Koster CG; Aerts JM
Biochim Biophys Acta; 2006 Oct; 1764(10):1626-32. PubMed ID: 17010683
[TBL] [Abstract][Full Text] [Related]
37. Serum inflammatory protein profiles in patients with chronic rhinosinusitis undergoing sinus surgery: a preliminary analysis.
Becker AM; Das S; Xia Z; Liu Z; Adam BL; Kountakis SE
Am J Rhinol; 2008; 22(2):139-43. PubMed ID: 18416969
[TBL] [Abstract][Full Text] [Related]
38. Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: effect of darbepoetin treatment.
Dursun E; Monari E; Cuoghi A; Bergamini S; Ozben B; Suleymanlar G; Tomasi A; Ozben T
Acta Histochem; 2010 Sep; 112(5):432-43. PubMed ID: 19500820
[TBL] [Abstract][Full Text] [Related]
39. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
40. SELDI-TOF-MS ProteinChip array profiling of tears from patients with dry eye.
Grus FH; Podust VN; Bruns K; Lackner K; Fu S; Dalmasso EA; Wirthlin A; Pfeiffer N
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):863-76. PubMed ID: 15728542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
